Stefan Plontke

Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany.

Mount Sinai Hospital is a 431-bed teaching, research and tertiary-care facility. Mount Sinai is a member of Sinai Health System, along with Schwab Rehabilitation Hospital, Sinai Community Institute, Sinai Medical Group and Sinai Children's Hospital.Mount Sinai provides health services to Chicago's West Side Community, as well as to others in the metropolitan area who require sophisticated medical and surgical care. Mount Sinai's medical offerings include a Level I trauma center; a child-abuse diagnosis, treatment and prevention unit; and a high-risk maternity and infant intensive-care program (Level III perinatal center)

bmp Ventures /Venture Capital/ (bmp Ventures) is the venture capital arm of bmp Ventures AG. It was founded by Oliver Borrmann in 1997. The firm is headquartered in Berlin, Germany, with another German office located in Magdeburg.